A real-world prospective single center open-label study to determine efficacy of dupilumab among patients with atopic dermatitis compared with Caucasian population
Latest Information Update: 07 Jul 2022
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2022 New trial record
- 01 Jul 2022 Results published in the Journal of the European Academy of Dermatology and Venereology